Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or Knee
Osteoarthritis

About this trial
This is an interventional treatment trial for Osteoarthritis focused on measuring Chronic pain, opioid, transdermal, osteoarthritis
Eligibility Criteria
Inclusion Criteria: clinical diagnosis of chronic osteoarthritis of the hip or knee for 1 year or longer. an average pain due to osteoarthritis of moderate, moderately-severe, or severe for the 14 days prior to enrollment. Exclusion Criteria: ingest opioid analgesics on a daily basis. ingest >2500 milligrams (mg) acetaminophen on a daily basis. require <20 mg or >80 mg of morphine (or opioid equivalents) per day for control of their osteoarthritis pain. Other protocol-specific exclusion/inclusion criteria may apply.
Sites / Locations
- Vista Medical Research
- Arizona Research Center
- Radiant Research
- Arizona Research Center
- ACRC/Arizona Clinical Research
- Advance Pain Medicine
- Eastgate Medical Center
- University Osteoporosis Ctr
- San Diego Arthritis & Osteoporosis Medical Clinic
- Scripps Clinic Rancho Bernard
- CNS Clinical Trials, Inc
- Mountain View Clinical Research
- Integrative Treatment Centers/Rocky Mtn Clin Res
- Rocky Mountain Center for Clinical Research
- Stamford Therapeutic Consortium
- Medical Specialists of the Palm Beaches
- University Clinical Research Deland
- Drug Study Institute
- Coastal Medical Research
- Coastal Medical Research
- Palm Beach Research Center
- Gold Coast Research
- Non-Surgical Orthopedic & Spine Center
- Columbus Internal Medical Associates
- MediSphere Medical Research Ctr.
- Primary Care Research
- Professional Clinical Research
- Sound Medical At West Front Primary Care
- Beth Israel Med Ctr Dept of Pain Medicine & Palliative Care
- All-Trials Clinical Research, LLC
- Keystone Clinical
- Altoona Center for Clinical Research
- University Orthopedics Center
- Clinical Research Center of Reading, LLP
- Low Country Rheumatology
- Brown Clinic
- Private Practice
- Team Research of Central Texas
- Radiant Research San Antonio Northeast
- ACCU Clinical Research Trials, Inc
- Wasatch Clinical Research
- Advance Pain Management & Rehab
- Evergreen Clinical Research Associates
- Internal Medicine Northwest
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
BTDS
Placebo
Buprenorphine transdermal patch 5, 10 or 20 micrograms/hour (mcg/h)
Placebo to match BTDS 5, 10 or 20 mcg/h